Market Research Logo

Australia Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

Australia Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

Summary

GlobalData’s new report, Australia Diabetes Care Devices Market Outlook to 2022, provides key market data on the Australia Diabetes Care Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Glucose Monitoring and Insulin Delivery.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022.
  • 2015 company shares and distribution shares data for Diabetes Care Devices market.
  • Global corporate-level profiles of key companies operating within the Australia Diabetes Care Devices market.
  • Key players covered include Medtronic plc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Diabetes Care Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Diabetes Care Devices Market, Australia
3.1 Diabetes Care Devices Market, Australia, Revenue ($m), 2008-2022
3.2 Diabetes Care Devices Market, Australia, Revenue Mix ($m), 2015
3.3 Diabetes Care Devices Market, Australia, Category Contribution by Revenue ($m), 2015
3.4 Diabetes Care Devices Market, Australia, Revenue ($m), 2008-2015
3.5 Diabetes Care Devices Market, Australia, Revenue ($m), 2015-2022
3.6 Diabetes Care Devices Market, Australia, Volume (Units), 2008-2022
3.7 Diabetes Care Devices Market, Australia, Volume (Units), 2008-2015
3.8 Diabetes Care Devices Market, Australia, Volume (Units), 2015-2022
3.9 Diabetes Care Devices Market, Australia, Company Share by Revenue ($m), 2015
4 Glucose Monitoring Market, Australia
4.1 Glucose Monitoring Market, Australia, Revenue Mix ($m), 2015
4.2 Glucose Monitoring Market, Australia, Segment Contribution (%), 2015
4.3 Glucose Monitoring Market, Australia, Revenue ($m), 2008-2015
4.4 Glucose Monitoring Market, Australia, Revenue ($m), 2015-2022
4.4.1 Blood Glucose Meters Market, Australia, Revenue ($m), by Segment, 2008-2015
4.4.2 Blood Glucose Meters Market, Australia, Revenue ($m), by Segment, 2015-2022
4.5 Glucose Monitoring Market, Australia, Volume (Units), 2008-2015
4.6 Glucose Monitoring Market, Australia, Volume (Units), 2015-2022
4.6.1 Blood Glucose Meters Market, Australia, Volume (Units), by Segment, 2008-2015
4.6.2 Blood Glucose Meters Market, Australia, Volume (Units), by Segment, 2015-2022
4.7 Glucose Monitoring Market, Australia, Distribution Share by Revenue ($m), 2014-2015
4.8 Glucose Monitoring Market, Australia, Company Share by Revenue ($m), 2015
5 Insulin Delivery Market, Australia
5.1 Insulin Delivery Market, Australia, Revenue Mix ($m), 2015
5.2 Insulin Delivery Market, Australia, Segment Contribution (%), 2015
5.3 Insulin Delivery Market, Australia, Revenue ($m), 2008-2015
5.4 Insulin Delivery Market, Australia, Revenue ($m), 2015-2022
5.4.1 Insulin Pens Market, Australia, Revenue ($m), by Segment, 2008-2015
5.4.2 Insulin Pumps Market, Australia, Revenue ($m), by Segment, 2008-2015
5.4.3 Insulin Pens Market, Australia, Revenue ($m), by Segment, 2015-2022
5.4.4 Insulin Pumps Market, Australia, Revenue ($m), by Segment, 2015-2022
5.5 Insulin Delivery Market, Australia, Volume (Units), 2008-2015
5.6 Insulin Delivery Market, Australia, Volume (Units), 2015-2022
5.6.1 Insulin Pens Market, Australia, Volume (Units), by Segment, 2008-2015
5.6.2 Insulin Pumps Market, Australia, Volume (Units), by Segment, 2008-2015
5.6.3 Insulin Pens Market, Australia, Volume (Units), by Segment, 2015-2022
5.6.4 Insulin Pumps Market, Australia, Volume (Units), by Segment, 2015-2022
5.7 Insulin Delivery Market, Australia, Distribution Share by Revenue ($m), 2014-2015
5.8 Insulin Delivery Market, Australia, Company Share by Revenue ($m), 2015
6 Overview of Key Companies in Australia, Diabetes Care Devices Market
6.1 F. Hoffmann-La Roche Ltd
6.1.1 Company Overview
6.2 Sanofi
6.2.1 Company Overview
6.3 Abbott Laboratories
6.3.1 Company Overview
6.4 Eli Lilly and Company
6.4.1 Company Overview
6.5 Medtronic plc
6.5.1 Company Overview
6.6 Becton Dickinson and Co
6.6.1 Company Overview
6.7 B. Braun Melsungen AG
6.7.1 Company Overview
6.8 Bayer HealthCare AG
6.8.1 Company Overview
6.9 Novo Nordisk A/S
6.9.1 Company Overview
6.10 Nipro Corp
6.10.1 Company Overview
6.11 DexCom Inc
6.11.1 Company Overview
6.12 I-Sens Inc.
6.12.1 Company Overview
7 Diabetes Care Devices Market Pipeline Products
8 Financial Deals Landscape
8.1 Partnerships
8.1.1 Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies
8.1.2 Medtronic and Qualcomm Life Enter into Co-Development Agreement
8.1.3 Metabolon Enters into Licensing Agreement with Synlab
9 Recent Developments
9.1 Corporate Communications
9.1.1 Jul 06, 2016: Mazor Robotics Receives Eleven Renaissance Systems Orders During the Second Quarter of 2016
9.1.2 Jun 30, 2016: UBI appoints Craig Coleman as Non-Executive Director
9.1.3 Mar 02, 2016: Universal Biosensors Appoints David Hoey as Non-Executive Director
9.1.4 Feb 19, 2016: Universal Biosensors Announces Retirement of CEO Paul Wright
9.2 Financial Announcements
9.2.1 Apr 21, 2016: Universal Biosensors Reports Q1 2016 Results
9.3 Other Significant Developments
9.3.1 Jul 28, 2016: DarioHealth is Now Direct-to-Consumer in Australia
9.3.2 Apr 01, 2016: Universal Biosensors - Update
10 Appendix
10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Company Share Analysis
10.1.5 Distribution Share Analysis
10.1.6 Benchmarking
10.2 GlobalData Consulting
10.3 Contact Us
10.4 Disclaimer
1.1 List of Tables
Table 1: Diabetes Care Devices Market, Australia, Revenue ($m), USD Constant, 2008-2022
Table 2: Diabetes Care Devices Market, Australia, Category Contribution by Revenue ($m), 2015
Table 3: Diabetes Care Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Table 4: Diabetes Care Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 5: Diabetes Care Devices Market, Australia, Volume (Units), 2008-2022
Table 6: Diabetes Care Devices Market, Australia, Volume (Units), Historic, 2008-2015
Table 7: Diabetes Care Devices Market, Australia, Volume (Units), Forecast, 2015-2022
Table 8: Diabetes Care Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2015
Table 9: Glucose Monitoring Market, Australia, Segment Contribution (%), 2015
Table 10: Glucose Monitoring Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Table 11: Glucose Monitoring Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 12: Blood Glucose Meters Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Table 13: Blood Glucose Meters Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 14: Glucose Monitoring Market, Australia, Volume (Units), Historic, 2008-2015
Table 15: Glucose Monitoring Market, Australia, Volume (Units), Forecast, 2015-2022
Table 16: Blood Glucose Meters Market, Australia, Volume (Units), Historic, 2008-2015
Table 17: Blood Glucose Meters Market, Australia, Volume (Units), Forecast, 2015-2022
Table 18: Glucose Monitoring Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2014-2015
Table 19: Glucose Monitoring Market, Australia, Company Share by Revenue ($m), USD Constant, 2015
Table 20: Insulin Delivery Market, Australia, Segment Contribution (%), 2015
Table 21: Insulin Delivery Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Table 22: Insulin Delivery Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 23: Insulin Pens Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Table 24: Insulin Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Table 25: Insulin Pens Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 26: Insulin Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 27: Insulin Delivery Market, Australia, Volume (Units), Historic, 2008-2015
Table 28: Insulin Delivery Market, Australia, Volume (Units), Forecast, 2015-2022
Table 29: Insulin Pens Market, Australia, Volume (Units), Historic, 2008-2015
Table 30: Insulin Pumps Market, Australia, Volume (Units), Historic, 2008-2015
Table 31: Insulin Pens Market, Australia, Volume (Units), Forecast, 2015-2022
Table 32: Insulin Pumps Market, Australia, Volume (Units), Forecast, 2015-2022
Table 33: Insulin Delivery Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2014-2015
Table 34: Insulin Delivery Market, Australia, Company Share by Revenue ($m), USD Constant, 2015
Table 35: Diabetes Care Devices Market Pipeline Products
Table 36: Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies
Table 37: Medtronic and Qualcomm Life Enter into Co-Development Agreement
Table 38: Metabolon Enters into Licensing Agreement with Synlab
1.2 List of Figures
Figure 1: Diabetes Care Devices Market, Australia, Revenue ($m), USD Constant, 2008-2022
Figure 2: Diabetes Care Devices Market, Australia, Revenue Mix ($m), 2015
Figure 3: Diabetes Care Devices Market, Australia, Category Contribution (%), 2015
Figure 4: Diabetes Care Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 5: Diabetes Care Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 6: Diabetes Care Devices Market, Australia, Volume (Units), 2008-2022
Figure 7: Diabetes Care Devices Market, Australia, Volume (Units), Historic, 2008-2015
Figure 8: Diabetes Care Devices Market, Australia, Volume (Units), Forecast, 2015-2022
Figure 9: Diabetes Care Devices Market, Australia, Company Share (%) 2015
Figure 10: Glucose Monitoring Market, Australia, Revenue Mix ($m), 2015
Figure 11: Glucose Monitoring Market, Australia, Segment Contribution (%), 2015
Figure 12: Glucose Monitoring Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 13: Glucose Monitoring Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 14: Blood Glucose Meters Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 15: Blood Glucose Meters Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 16: Glucose Monitoring Market, Australia, Volume (Units), Historic, 2008-2015
Figure 17: Glucose Monitoring Market, Australia, Volume (Units), Forecast, 2015-2022
Figure 18: Blood Glucose Meters Market, Australia, Volume (Units), Historic, 2008-2015
Figure 19: Blood Glucose Meters Market, Australia, Volume (Units), Forecast, 2015-2022
Figure 20: Glucose Monitoring Market, Australia, Company Share (%) 2015
Figure 21: Insulin Delivery Market, Australia, Revenue Mix ($m), 2015
Figure 22: Insulin Delivery Market, Australia, Segment Contribution (%), 2015
Figure 23: Insulin Delivery Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 24: Insulin Delivery Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 25: Insulin Pens Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 26: Insulin Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 27: Insulin Pens Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 28: Insulin Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 29: Insulin Delivery Market, Australia, Volume (Units), Historic, 2008-2015
Figure 30: Insulin Delivery Market, Australia, Volume (Units), Forecast, 2015-2022
Figure 31: Insulin Pens Market, Australia, Volume (Units), Historic, 2008-2015
Figure 32: Insulin Pumps Market, Australia, Volume (Units), Historic, 2008-2015
Figure 33: Insulin Pens Market, Australia, Volume (Units), Forecast, 2015-2022
Figure 34: Insulin Pumps Market, Australia, Volume (Units), Forecast, 2015-2022
Figure 35: Insulin Delivery Market, Australia, Company Share (%) 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report